drugset / Trial / NCT00656227
A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision
RandomizedFactorialTriple-blindPrevention
Summary
This trial will investigate whether four doses of RN1001 (20ng, 50ng, 100ng and 200ng) are efficacious in preventing or reducing the resultant scar, as compared to placebo, when applied intradermally to wound margins following excision of benign naevi situated on the head and neck.
Timeline
- Start
- 2004-04
- Primary completion
- 2007-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avotermin | Protein / enzyme biologic | 20 ng | Other |
| Subject | Avotermin | Protein / enzyme biologic | 50 ng | Other |
| Subject | Avotermin | Protein / enzyme biologic | 100 ng | Other |
| Subject | Avotermin | Protein / enzyme biologic | 200 ng | Other |